Unable to connect, retrying...
Online collaborative whiteboard. Powerful, engaging with timer, emoji's, commenting and voting.
Search for RSS feeds

Drug Safety Update: Finasteride: reminder of the risk psych...effects (which may persist after discontinuation of treatment)

A patient alert card is being introduced for men taking finasteride to help raise awareness of the risk of psychiatric side effects and sexual dysfunction, including the potential for sexual dysf...

https://www.rpharms.com/news/details//Drug-Safety-Update-Finasteride-reminder-of-the-risk-psychiatric-side-effects-and-of-sexual-side-effects-which-may-persist-after-discontinuation-of-treatment

MHRA Device Safety Information: Counterfeits and unbranded ...may fail to work correctly or worsen choking incidents if used

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued Device Safety information for counterfeits and unbranded copies of LifeVac anti-choking devices. Anti-choking devices are...

https://www.rpharms.com/news/details//MHRA-Device-Safety-Information-Counterfeits-and-unbranded-copies-of-LifeVac-anti-choking-devices-may-fail-to-work-correctly-or-worsen-choking-incidents-if-used

Class 2 Medicines Recall: medac GmbH (t/a medac Pharma LLP)... solution for injection/infusion (folinic acid 400mg/8ml vial)

The Medicines and Healthcare products Regulatory Agency (MHRA) has published a Class 2 medicines recall for a specific batch of medac GmbH (t/a medac Pharma LLP) Sodiofolin 50 mg/ml, solution for...

https://www.rpharms.com/news/details//Class-2-Medicines-Recall-medac-GmbH-ta-medac-Pharma-LLP-Sodiofolin-50-mgml-solution-for-injectioninfusion-folinic-acid-400mg8ml-vial

Drug Safety update: Pseudoephedrine: very rare risk of post...PRES) and reversible cerebral vasoconstriction syndrome (RCVS)

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a Drug Safety Update for pseudoephedrine. There have been very rare reports of posterior reversible encephalopathy syndro...

https://www.rpharms.com/news/details//Drug-Safety-update-Pseudoephedrine-very-rare-risk-of-posterior-reversible-encephalopathy-syndrome-PRES-and-reversible-cerebral-vasoconstriction-syndrome-RCVS

Omega-3-acid ethyl ester medicines: dose-dependent increase...blished cardiovascular diseases or cardiovascular risk factors

Systematic reviews and meta-analyses of randomised controlled trials have highlighted a dose-dependent increased risk of atrial fibrillation in patients with established cardiovascular diseases o...

https://www.rpharms.com/news/details//Omega-3-acid-ethyl-ester-medicines-dose-dependent-increased-risk-of-atrial-fibrillation-in-patients-with-established-cardiovascular-diseases-or-cardiovascular-risk-factors

Legislative changes to enable the prescribing supply and ad...ering of controlled drugs by certain healthcare professionals.

The Home Office has made changes to the Misuse of Drugs Regulations 2001 to enable the prescribing, supply and administering of controlled drugs by certain healthcare professionals. Paramedic ind...

https://www.rpharms.com/news/details//Legislative-changes-to-enable-the-prescribing-supply-and-administering-of-controlled-drugs-by-certain-healthcare-professionals-

Drug Safety Alert: Valproate: new safety and educational ma...ort regulatory measures in men and women under 55 years of age

New safety and educational materials have been introduced for men and women and healthcare professionals to reduce the harms from valproate (Belvo, Convulex, Depakote, Dyzantil, Epilim, Epilim Ch...

https://www.rpharms.com/news/details//Drug-Safety-Alert-Valproate-new-safety-and-educational-materials-to-support-regulatory-measures-in-men-and-women-under-55-years-of-age

Drug Safety Update: Vitamin B12 (hydroxocobalamin, cyanocob... known cobalt allergy to be vigilant for sensitivity reactions

The medicines used to treat vitamin B12 deficiency (hydroxocobalamin, cyanocobalamin) contain cobalt. There are case reports in the literature describing cobalt sensitivity-type reactions in pati...

https://www.rpharms.com/news/details//Drug-Safety-Update-Vitamin-B12-hydroxocobalamin-cyanocobalamin-advise-patients-with-known-cobalt-allergy-to-be-vigilant-for-sensitivity-reactions

National Patient Safety Alert: Potential for inappropriate ...f insulin when switching insulin degludec (Tresiba®) products

A Medicine Supply Notification issued on 24 May 2023, detailed a shortage of Tresiba® (insulin degludec) FlexTouch® 100units/ml solution for injection 3ml pre-filled pens. Advice on how to man

https://www.rpharms.com/news/details//National-Patient-Safety-Alert-Potential-for-inappropriate-dosing-of-insulin-when-switching-insulin-degludec-Tresiba-products

National Patient Safety Alert: Potential contamination of s...h Burkholderia cenocepacia – measures to reduce patient risk

UKHSA is investigating an outbreak of Burkholderia cenocepacia involving individuals across the UK. This is an emerging issue and, following testing, B. cenocepacia was recovered from some lubric...

https://www.rpharms.com/news/details//National-Patient-Safety-Alert--Potential-contamination-of-some-carbomer-containing-lubricating-eye-products-with-Burkholderia-cenocepacia--measures-to-reduce-patient-risk

Class 4 Medicines Defect Information: Strandhaven Ltd t/a Somex Pharma, Clarithromycin 250mg and 500mg film-coated tablets

Strandhaven Limited t/a Somex Pharma has informed the Medicines and Healthcare products Regulatory Agency (MHRA)regarding an error with the Patient Information Leaflets (PILs) that have been pack...

https://www.rpharms.com/news/details//Class-4-Medicines-Defect-Information-Strandhaven-Ltd-ta-Somex-Pharma-Clarithromycin-250mg-and-500mg-film-coated-tablets

National Patient Safety Alert: Valproate: organisations to ...ht of prescribing to new patients and existing female patients

The MHRA is asking organisations to put a plan in place to implement new regulatory measures for sodium valproate, valproic acid and valproate semisodium (valproate). This follows a comprehensive...

https://www.rpharms.com/news/details//National-Patient-Safety-Alert-Valproate-organisations-to-prepare-for-new-regulatory-measures-for-oversight-of-prescribing-to-new-patients-and-existing-female-patients

Isotretinoin (Roaccutane): introduction of new safety measu...the initiation of treatment for patients under 18 years of age

The Medicines and Healthcare Products Regulatory Agency (MHRA) has introduced new safety measures for Isotretinoin (Roaccutane). These new safety measures strengthen the safe use of isotretinoin ...

https://www.rpharms.com/news/details//Isotretinoin-Roaccutane-introduction-of-new-safety-measures-including-additional-oversight-of-the-initiation-of-treatment-for-patients-under-18-years-of-age

Class 4 Medicines Defect Information: Sandoz Limited, Zinac... infusion vials (all strengths, including stock in GSK livery)

The Medicines and Healthcare products Regulatory Agency (MHRA) has published a Class 4 Medicines Defect Information for Sandoz Limited, Zinacef powder for solution for injection or infusion vials...

https://www.rpharms.com/news/details//Class-4-Medicines-Defect-Information-Sandoz-Limited-Zinacef-powder-for-solution-for-injection-or-infusion-vials-all-strengths-including-stock-in-GSK-livery

National Patient Safety Alert: Shortage of methylphenidate ...xamfetamine capsules, and guanfacine prolonged-release tablets

A National Patient Safety Alert has been issued due supply disruptions affecting various strengths of specified medications which are licensed for thetreatment of attention deficit hyperactivity ...

https://www.rpharms.com/news/details//National-Patient-Safety-Alert-Shortage-of-methylphenidate-prolonged-release-capsules-and-tablets-lisdexamfetamine-capsules-and-guanfacine-prolonged-release-tablets

Class 4 Medicines Notification: Accord Healthcare Limited, ...n Hydrochloride 20 mg/ml Concentrate for Solution for Infusion

The Medicines and Healthcare products Regulatory Agency (MHRA) has published a Class 4 Medicines Notification for Irinotecan Hydrochloride 20 mg/ml Concentrate for Solution for Infusion.Accord He...

https://www.rpharms.com/news/details//Class-4-Medicines-Notification-Accord-Healthcare-Limited-UK-Irinotecan-Hydrochloride-20-mgml-Concentrate-for-Solution-for-Infusion

Drug Safety Update: Hyoscine hydrobromide patches (Scopoder...: risk of anticholinergic side effects, including hyperthermia

The Medicines and Healthcare products Regulatory Agency (MHRA) has published a Drug Safety Update for hyoscine hydrobromide patches (Scopoderm 1.5mg Patch or Scopoderm TTS Patch). There have been...

https://www.rpharms.com/news/details//Drug-Safety-Update-Hyoscine-hydrobromide-patches-Scopoderm-15mg-Patch-or-Scopoderm-TTS-Patch-risk-of-anticholinergic-side-effects-including-hyperthermia

Class 2 Medicines Recall: medac GmbH (t/a medac Pharma LLP)...olin 50 mg/ml solution for injection/infusion (400mg/8ml vial)

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 2 recall for specified batches of Sodiofolin 50 mg/ml, solution for injection/infusion (400mg/8ml vial),due to pa...

https://www.rpharms.com/news/details//Class-2-Medicines-Recall-medac-GmbH-ta-medac-Pharma-LLP-Sodiofolin-50-mgml-solution-for-injectioninfusion-400mg8ml-vial

Class 2 Medicines Recall: Aventis Pharma Limited (t/a Sanof...film-coated tablets & Sabril 500 mg granules for oral solution

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a Class 2 recall for specified batches of Sabril tablets and Sabril granules as a precautionary measure due to the detect...

https://www.rpharms.com/news/details//Class-2-Medicines-Recall-Aventis-Pharma-Limited-ta-Sanofi-Sabril-500-mg-film-coated-tablets--Sabril-500-mg-granules-for-oral-solution

Class 2 Medicines Recall: medac GmbH (t/a medac Pharma LLP)...e 100mg, 200mg & 500mg powder for solution for injection vials

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a Class 2 recall for specific batches of medac GmbH (t/a medac Pharma LLP), dacarbazine 100mg, 200mg and 500mg powder for...

https://www.rpharms.com/news/details//Class-2-Medicines-Recall-medac-GmbH-ta-medac-Pharma-LLP-Dacarbazine-100mg-200mg--500mg-powder-for-solution-for-injection-vials

Class 4 Medicines Defect Information: Novartis Pharmaceutic...20mg powder and solvent for Solution for injection or infusion

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a Class 4 recall for Novartis Pharmaceuticals, Simulect 10mg & 20mg powder and solvent for Solution for injection or infu...

https://www.rpharms.com/news/details//-Class-4-Medicines-Defect-Information-Novartis-Pharmaceuticals-Simulect-10mg--20mg-powder-and-solvent-for-Solution-for-injection-or-infusion

Class 4 Medicines Defect Information: Sandoz Limited, Co-amoxiclav 125/31.25mg/5ml, 250/62.5mg/5ml powder for oral suspension

Sandoz limited has informed theMedicines and Healthcare products Regulatory Agency (MHRA) that Co-amoxiclav 125/31.25mg/5ml, 250/62.5mg/5ml powder for oral suspension are not sugar free despite t...

https://www.rpharms.com/news/details//Class-4-Medicines-Defect-Information-Sandoz-Limited-Co-amoxiclav-1253125mg5ml-250625mg5ml-powder-for-oral-suspension

Class 2 Medicines Recall: Ferring Pharmaceuticals Limited, ... Depot 3.75mg, Powder and solvent for suspension for injection

Ferring Pharmaceuticals Limited is recalling certain batches of GONAPEPTYL Depot 3.75mg due to a defect noticed in the seal of the needle wrapping for the CE-marked 30-millimeter (30mm) needle fo...

https://www.rpharms.com/news/details//Class-2-Medicines-Recall-Ferring-Pharmaceuticals-Limited-GONAPEPTYL-Depot-375mg-Powder-and-solvent-for-suspension-for-injection

Class 4 Medicines Defect Information: Macarthys Laboratorie..., Venlafaxine XL 150mg, 225mg, 300mg prolonged-release tablets

Additional to the batches included in the previous Class 4 Medicines Notification from 16th November 2022. Martindale Pharma has made the MHRA aware that the GTIN in the 2D barcode and the printe...

https://www.rpharms.com/news/details//Class-4-Medicines-Defect-Information-Macarthys-Laboratories-ta-Martindale-Pharma-Venlafaxine-XL-150mg-225mg-300mg-prolonged-release-tablets

Class 4 Medicines Defect Information: Thornton & Ross Ltd, ...1mg/mL Oral Solution BP - Sugar Free, Methadone Mixture 1mg/ml

Thornton & Ross Ltd has informed the Medicines and Healthcare products Regulatory Agency (MHRA) that specific batches of Methadone 1mg/mL Oral Solution BP Sugar Free have been packaged with the i...

https://www.rpharms.com/news/details//Class-4-Medicines-Defect-Information-Thornton--Ross-Ltd-Methadone-1mgmL-Oral-Solution-BP---Sugar-Free-Methadone-Mixture-1mgml-

Company led medicines recall: Vertical Pharma Resources Ltd...IPS Pharma, Levothyroxine Oral Suspension (Various Strengths)

IPS Pharma is recalling specific batches of levothyroxine oral suspension from pharmacies and impacted patients due to the concentration of levothyroxine being greater than the amount stated on t...

https://www.rpharms.com/news/details//Company-led-medicines-recall-Vertical-Pharma-Resources-Ltd-TA-IPS-Pharma-Levothyroxine-Oral-Suspension-Various-Strengths-unlicensed-medicine

Group A Streptococcus: reinstatement of NICE sore throat gu...nd young people and withdrawal of NHS England interim guidance

The NHS England/UKHSA Incident Management Team Group A Streptococcus interim clinical guidance for primary and community care settings has been retired as of 15 February 2023. This guidance asked...

https://www.rpharms.com/news/details//Group-A-Streptococcus-reinstatement-of-NICE-sore-throat-guidance-for-children-and-young-people-and-withdrawal-of-NHS-England-interim-guidance

Company led medicines recall: Mawdsley-Brooks & Company Lim...phenazin-neuraxpharm® D 25 & 100 mg/ml Solution for Injection

Mawdsley-Brooks & Company Limited is recalling specific batches of Fluphenazin-neuraxpharm® D 25 & 100 mg/ml Solution for injection as a precautionary measure, due to validation tests demo

https://www.rpharms.com/news/details//Company-led-medicines-recall-Mawdsley-Brooks--Company-Limited-Fluphenazin-neuraxpharm-D-25--100-mgml-Solution-for-Injection

National Patient Safety Alert: Use of oxygen cylinders where patients do not have access to medical gas pipeline systems

NHS England has published a National Patient Safety Alert on the use of oxygen cylinders where patients do not have access to medical gas pipeline systems. To help NHS organisations prevent risks...

https://www.rpharms.com/news/details//National-Patient-Safety-Alert-Use-of-oxygen-cylinders-where-patients-do-not-have-access-to-medical-gas-pipeline-systems

UKHSA - Urgent public health message: Actions needed in response to health protection issues identified in asylum seekers

The UK Health Security Agency (UKHSA) has published an urgent public health message in response to health protection issues identified in asylum seekers. There has been a number of infectious dis...

https://www.rpharms.com/news/details//UKHSA---Urgent-public-health-message-Actions-needed-in-response-to-health-protection-issues-identified-in-asylum-seekers-

Further 5 Serious Shortage Protocols (SSPs) phenoxymethylpenicillin products to enable the supply of alternative antibiotics

The Department of Health and Social Care (DHSC) hasissued 5 further Serious Shortage Protocols (SSPs)for phenoxymethylpenicillin products which enables therapeutic substitution. These are the 5 S...

https://www.rpharms.com/news/details//Further-5-Serious-Shortage-Protocols-SSPs-phenoxymethylpenicillin-products-to-enable-the-supply-of-alternative-antibiotics

Letter to Pharmacy teams from the Chief Pharmaceutical Offi...egarding Group A streptococcus and antibiotic supply (England)

A letter from the Chief Pharmaceutical Officer has been published on the 8th December 2022 and is being cascaded to pharmacy teams. The letter provides an update on Group A streptococcus and anti...

https://www.rpharms.com/news/details//Letter-to-Pharmacy-teams-from-the-Chief-Pharmaceutical-Officer-regarding-Group-A-streptococcus-and-antibiotic-supply-England-

Class 4 Medicines Defect Information: Macarthys Laboratorie...indale Pharma, Venlafaxine XL 300 mg prolonged-release tablets

Martindale Pharma has made the Medicines and Healthcare products Regulatory Agency (MHRA) aware that the GTIN in the 2D barcode and the printed variable data represents the branded version of the...

https://www.rpharms.com/news/details//Class-4-Medicines-Defect-Information-Macarthys-Laboratories-ta-Martindale-Pharma-Venlafaxine-XL-300-mg-prolonged-release-tablets

Class 2 Medicines Recall: hameln pharma ltd, Amiodarone Hyd...de 50 mg/ml Concentrate for Solution for Injection or Infusion

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a medicines recall, hameln pharma ltd is initiating a recall of a batch of Amiodarone Hydrochloride 50 mg/ml concentrate ...

https://www.rpharms.com/news/details//Class-2-Medicines-Recall-hameln-pharma-ltd-Amiodarone-Hydrochloride-50-mgml-Concentrate-for-Solution-for-Injection-or-Infusion

Drug Safety Update: Methylphenidate long-acting (modified-r... switching between products due to differences in formulations

The Medicines and Healthcare products Regulatory Agency (MHRA) has advised that prescribers and dispensers should use caution if switching patients between different long-acting formulations of m...

https://www.rpharms.com/news/details//Drug-Safety-Update-Methylphenidate-long-acting-modified-release-preparations-caution-if-switching-between-products-due-to-differences-in-formulations

Class 4 Medicines Defect Information: Rosemont Pharmaceutic...in 4mg/ml Oral Suspension & Sildenafil 10mg/ml Oral Suspension

Rosemont Pharmaceuticals Ltd. has made the MHRA aware that the expiry dates stamped on the base of the bottle are incorrect for the above 2 batches of Atorvastatin 4mg/ml Oral Suspension and 2 ba...

https://www.rpharms.com/news/details//Class-4-Medicines-Defect-Information-Rosemont-Pharmaceuticals-Ltd-Atorvastatin-4mgml-Oral-Suspension--Sildenafil-10mgml-Oral-Suspension

Class 2 Medicines Recall: Hikma Pharmaceuticals USA Inc, Lo...l Injection, Lorazepam 4mg/ml Injection (unlicensed medicines)

Hikma Pharmaceuticals USA Inc are recalling specified batches of lorazepam 2mg/ml Injection and lorazepam 4mg/ml Injection (unlicensed medicines) due to an out of specification result with relate...

https://www.rpharms.com/news/details//Class-2-Medicines-Recall-Hikma-Pharmaceuticals-USA-Inc-Lorazepam-2mgml-Injection-Lorazepam-4mgml-Injection-unlicensed-medicines

Drug Safety Update: Nebulised asthma rescue therapy in chil...ric asthma should be initiated and managed only by specialists

The Medicines and Healthcare products Regulatory Agency (MHRA) has published a drug safety update. Use of a nebuliser purchased independently of medical advice for use in the home to deliver nebu...

https://www.rpharms.com/news/details//Drug-Safety-Update-Nebulised-asthma-rescue-therapy-in-children-home-use-of-nebulisers-in-paediatric-asthma-should-be-initiated-and-managed-only-by-specialists

National Patient Safety Alert: Class 1 Medicines Recall Not...Mexiletine hydrochloride 50mg, 100mg and 200 mg Hard Capsules.

Clinigen Healthcare Ltd is initiating a recall of three batches of Mexiletine hydrochloride hard capsules due to a potential risk of underdose or overdose, which could have consequences for the s...

https://www.rpharms.com/news/details//National-Patient-Safety-Alert-Class-1-Medicines-Recall-Notification-Recall-of-Mexiletine-hydrochloride-50mg-100mg-and-200-mg-Hard-Capsules

Class 4 Medicines Defect Information: Novo Nordisk Limited,...uch® 100 units/ml, Saxenda® FlexTouch® (liraglutide) 6mg/ml

Novo Nordisk Limited has identified a defect that affects specific batches of NovoRapid FlexTouch prefilled pen device and batches of Saxenda FlexTouch prefilled pen device in the UK. The defect ...

https://www.rpharms.com/news/details//Class-4-Medicines-Defect-Information-Novo-Nordisk-Limited-NovoRapid-FlexTouch-100-unitsml-Saxenda-FlexTouch-liraglutide-6mgml

Class 2 Medicines Recall: hameln pharma ltd, Amiodarone Hyd...oride 50 mg/ml Concentrate for Solution for Injection/Infusion

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a Class 2 recall, hameln pharma ltd is initiating a recall of a specific batch of Amiodarone Hydrochloride 50 mg/ml Conce...

https://www.rpharms.com/news/details//Class-2-Medicines-Recall-hameln-pharma-ltd-Amiodarone-Hydrochloride-50-mgml-Concentrate-for-Solution-for-InjectionInfusion

Urgent Public Health Message: Urgent actions in response to...of Vaccine Derived Polio Virus type 2 in London sewage samples

UK Health Security Agency have issused a urgent public health message for the NHS on the detection of Vaccine Derived Polio Virus type 2 in London sewage samples. Health professionals are urged t...

https://www.rpharms.com/news/details//Urgent-Public-Health-Message-Urgent-actions-in-response-to-detection-of-Vaccine-Derived-Polio-Virus-type-2-in-London-sewage-samples

Class 4 Medicines Defect Information: Pfizer Limited, Depo-...ne 40 mg/mL (1 mL and 2 mL vials – single vial preparations)

Pfizer Limited have informed the Medicines and Healthcare products Regulatory Agency that an outdated version of the Patient Information Leaflet (PIL) has been included in the packaging of specif...

https://www.rpharms.com/news/details//Class-4-Medicines-Defect-Information-Pfizer-Limited-Depo-Medrone-with-Lidocaine-40-mgmL-1-mL-and-2-mL-vials--single-vial-preparations

Class 4 Medicines Defect Information: Benzylpenicillin benz...4 Million I.U. powder and solvent for suspension for injection

Brancaster Pharma Limited have notified the Medicines and Healthcare products Regulatory Agency (MHRA)of an issue relating to the label affixed to the 5mL ampoule of Water for Injections (solvent...

https://www.rpharms.com/news/details//Class-4-Medicines-Defect-Information-Benzylpenicillin-benzathine-12-Million-IU-and-24-Million-IU-powder-and-solvent-for-suspension-for-injection

Company led medicines recall: Advanced Accelerator Applicat...(Kit for the preparation of gallium Ga 68 dotatate injection)

Advanced Accelerator Applications is recalling specific batches of this product as a precautionary measure due to an out of specification result that was identified during stability testing. Furt...

https://www.rpharms.com/news/details//Company-led-medicines-recall-Advanced-Accelerator-Applications-NETSPOT-Kit-for-the-preparation-of-gallium-Ga-68-dotatate-injection-unlicensed-medicine

Class 4 Medicines Defect Information, Ayrton Saunders Limit...dipropionate 50 micrograms/dose Nasal Spray (Various Liveries)

Ayrton Saunders Limited have identified an error relating to the Braille printed on the cartons. Further information and advice for healthcare professionals is available on the MHRA website.

https://www.rpharms.com/news/details//Class-4-Medicines-Defect-Information-Ayrton-Saunders-Limited-Beclometasone-dipropionate-50-microgramsdose-Nasal-Spray-Various-Liveries

Class 4 Medicines Defect Information: Atnahs Pharma UK Limi...ts (all strengths), Naprosyn EC 500mg Gastro-Resistant Tablets

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 4 medicines defect information for Atnahs Pharma UK Limited, Naprosyn Tablets (all strengths) and Naprosyn EC 500...

https://www.rpharms.com/news/details//Class-4-Medicines-Defect-Information-Atnahs-Pharma-UK-Limited-Naprosyn-Tablets-all-strengths-Naprosyn-EC-500mg-Gastro-Resistant-Tablets

Class 4 Medicines Defect Information: Atnahs Pharma UK Limi...ts (all strengths), Naprosyn EC 250mg Gastro-Resistant Tablets

Atnahs Pharma UK Limited have identified missing information on the PIL of certain batches ofNaprosyn Tablets (all strengths), Naprosyn EC 250mg Gastro-Resistant Tablets. Further information and ...

https://www.rpharms.com/news/details//Class-4-Medicines-Defect-Information-Atnahs-Pharma-UK-Limited-Naprosyn-Tablets-all-strengths-Naprosyn-EC-250mg-Gastro-Resistant-Tablets

UPDATED PRODUCT AND BATCH - Class 2 Medicines Recall variou...parallel distributor companies, Irbesartan-containing products

There is one additional product and batch that has been added to this recall. Further information on the affected batches and advice for healthcare professionals can be found on theMHRA website.

https://www.rpharms.com/news/details//UPDATED-PRODUCT-AND-BATCH---Class-2-Medicines-Recall-various-Marketing-Authorisation-Holders-and-parallel-distributor-companies-Irbesartan-containing-products

Class 2 Medicines Recall: Various Marketing Authorisation H...parallel distributor companies, Irbesartan-containing products

Specific batches of products are recalled by the Marketing Authorisation Holders and parallel distributor companies as a precautionary measure due to contamination with an impurity called 5-(4’...

https://www.rpharms.com/news/details//Class-2-Medicines-Recall-Various-Marketing-Authorisation-Holders-and-parallel-distributor-companies-Irbesartan-containing-products-

Class 2 Medicines Recall: Cold & Flu Relief Capsules (GSL) ...us Liveries, Wrafton Laboratories Limited (trading as Perrigo)

Perrigo are recalling specified batches of Cold & Flu Relief Capsules (GSL) – Various Liveries, due to an error on the leaflet and carton for the products . The leaflet and carton incorrectl

https://www.rpharms.com/news/details//Class-2-Medicines-Recall-Cold--Flu-Relief-Capsules-GSL--Various-Liveries-Wrafton-Laboratories-Limited-trading-as-Perrigo-

UPDATE: Class 4 Medicines Defect Information: Crescent Phar...niRing 0.120 mg/0.015 mg per 24 hours, vaginal delivery system

The MHRA has been informed that further batches were released which did not contain the safety information, as detailed in the original class 4 notification. Please see details relating to the or...

https://www.rpharms.com/news/details//UPDATE-Class-4-Medicines-Defect-Information-Crescent-Pharma-Ltd-SyreniRing-0120-mg0015-mg-per-24-hours-vaginal-delivery-system

MHRA - Class 2 Medicines Recall: Tesco Flu-Max All In One C...h & Cold Powder for Oral Solution Wrafton Laboratoires Limited

Perrigo are recalling batches of Tesco Flu-Max All In One Chesty Cough & Cold Powder due to an error on the sachet contained within the outer carton. Further information and advice for healthcare

https://www.rpharms.com/news/details//MHRA---Class-2-Medicines-Recall-Tesco-Flu-Max-All-In-One-Chesty-Cough--Cold-Powder-for-Oral-Solution-Wrafton-Laboratoires-Limited

Update on Class 2 Medicines Recall: Various Marketing Autho...parallel distributor companies, Irbesartan-containing products

MHRA havemade an update to the Class 2 Medicines Recall: Various Marketing Authorisation Holders and parallel distributor companies, Irbesartan-containing products. The update is to an expiry dat...

https://www.rpharms.com/news/details//Update-on-Class-2-Medicines-Recall-Various-Marketing-Authorisation-Holders-and-parallel-distributor-companies-Irbesartan-containing-products

Class 2 Medicines Recall: Various Marketing Authorisation H...parallel distributor companies, Irbesartan-containing products

Specific batches of products are being recalled by the Marketing Authorisation Holders and parallel distributor companies as a precautionary measure due to contamination with an impurity called 5...

https://www.rpharms.com/news/details//Class-2-Medicines-Recall-Various-Marketing-Authorisation-Holders-and-parallel-distributor-companies-Irbesartan-containing-products

Public Health England guidance: COVID-19: management of sta...posed patients or residents in health and social care settings

Public Health England has issued guidance: COVID-19: management of staff and exposed patients or residents in health and social care settings If there is a likelihood that staff absence creates a...

https://www.rpharms.com/news/details//Public-Health-England-guidance-COVID-19-management-of-staff-and-exposed-patients-or-residents-in-health-and-social-care-settings

Drug Safety Update: Chloramphenicol eye drops containing borax or boric acid buffers: use in children younger than 2 years

The MHRA has issued a drug safety update: chloramphenicol eye drops containing borax or boric acid buffers: use in children younger than 2 years. Following a review of the available toxicological...

https://www.rpharms.com/news/details//Drug-Safety-Update-Chloramphenicol-eye-drops-containing-borax-or-boric-acid-buffers-use-in-children-younger-than-2-years

Company led medicines recall: Morphine Syringe 50mg/50ml (u...d Magnesium Sulphate 8mmol/20ml infusion (unlicensed medicine)

Nova Laboratories Limited is recalling specific batches of the impacted products, Morphine Syringe 50mg/50ml and Magnesium Sulphate 8mmol/20ml infusion due to a potential risk of contamination. F...

https://www.rpharms.com/news/details//Company-led-medicines-recall-Morphine-Syringe-50mg50ml-unlicensed-medicine-and-Magnesium-Sulphate-8mmol20ml-infusion-unlicensed-medicine

COVID-19 Vaccine Moderna and Pfizer/BioNTech COVID-19 vacci...ditis and pericarditis– revisions to the product information

The Medicines and Healthcare products Regulatory Agency (MHRA) and the Government’s independent expert advisory body, the Commission on Human Medicines (CHM), has conducted a thorough review of

https://www.rpharms.com/news/details//COVID-19-Vaccine-Moderna-and-PfizerBioNTech-COVID-19-vaccine-myocarditis-and-pericarditis-revisions-to-the-product-information

Class 2 Medicines Recall: Bristol Laboratories Limited, Bro...UK Ltd, Irbesartan-containing and Losartan-containing products

Specific batches of products supplied by Bristol Laboratories Limited, Brown & Burk UK Limited and Teva UK Limited are being recalled due to presence of a mutagenic impurity. Further information

https://www.rpharms.com/news/details//Class-2-Medicines-Recall-Bristol-Laboratories-Limited-Brown--Burk-UK-Ltd-Teva-UK-Ltd-Irbesartan-containing-and-Losartan-containing-products

Class 3 medicines recall: Easyhaler salbutamol sulfate 100 ...s per actuation/200 micrograms per actuation inhalation powder

Orion Corporation T/A Orion Pharma (UK) Ltd has informed the Medicines and Healthcare products Regulatory Agency (MHRA) that it is recalling specific batches as a precautionary measure due to an ...

https://www.rpharms.com/news/details//Class-3-medicines-recall-Easyhaler-salbutamol-sulfate-100-micrograms-per-actuation200-micrograms-per-actuation-inhalation-powder

NHS Discharge Medicines Service – Essential Service: Tool...rmacy staff in community, primary and secondary care (England)

NHS England has produced a toolkit on the NHS Discharge Medicines Service for pharmacy staff in community, primary and secondary care. This toolkit supports cross-sector implementation of the NHS...

https://www.rpharms.com/news/details//NHS-Discharge-Medicines-Service--Essential-Service-Toolkit-for-pharmacy-staff-in-community-primary-and-secondary-care-England

Deployment of COVID-19 Vaccine Oxford/AstraZeneca: implicat...r governance, handling and preparation of vaccines – England

Keith Ridge, Chief Pharmaceutical Officer for England, has issued a letter about the Deployment of COVID-19 Vaccine Oxford/AstraZeneca: implications for governance, handling and preparation of va...

https://www.rpharms.com/news/details//Deployment-of-COVID-19-Vaccine-OxfordAstraZeneca-implications-for-governance-handling-and-preparation-of-vaccines--England

Class 2 Medicines Recall, medac GmbH (T/A medac Pharma LLP)... Solution for Injection 100mg/2ml, PL 11587/0005, EL (20) A/61

Further to Drug Alert EL (20)A/52 issued on 11 November 2020, medac Pharma LLP is recalling further batches of products following inspection of vials showing hairline damage to the shoulder of th...

https://www.rpharms.com/news/details//Class-2-Medicines-Recall-medac-GmbH-TA-medac-Pharma-LLP-Sodiofolin-50mgml-Solution-for-Injection-100mg2ml-PL-115870005-EL-20-A61

Community pharmacy in the context of coronavirus (COVID-19): UPDATED guidance and standard operating procedures (England)

NHS England has issued updated guidance and standard operating procedures for Community pharmacy in the context of coronavirus (COVID-19). The guidance and SOP can be accessed here. If you have a...

https://www.rpharms.com/news/details//Community-pharmacy-in-the-context-of-coronavirus-COVID-19-UPDATED-guidance-and-standard-operating-procedures-England